Transforming medical devices for improved patient outcomes

PRESENTATIONS

Clinicians and academics regularly present key data updates to the interventional cardiology community.  See below for a representative list of recent presentations, and click on the society link to see them. (Note some societies require membership to access presentations.)

TCT 2016
Micell Clinical Trials Program – MiStent® Sirolimus Eluting Stent
David Kandzari, MD; November 2016 – Presentation

CRT 2016
MiStent SES® Program Technology and Clinical Data Update
David Kandzari, MD; February 2016 – Presentation

Four Year Clinical Outcomes with MiStent SES: A Unique DES using an Absorbable Polymer Coating with Crystalline Drug

David Kandzari, MD; John Ormiston, MBChB; Alexandra Lansky, MD; Dennis Donohoe, MD; Mathias Vrolix, MD; Stephan Verheye, MD; Danny Schoors, MD, PhD; William Wijns, MD, PhD; February 2016 ‒ Poster

TCT 2015
Device and Clinical Program Highlights: Micell_MiStent SES® Absorbable Polymer Sirolimus Eluting Coronary Stent System
Alexandra Lansky, MD; October 2015 – Presentation

EuroPCR 2015
A matched comparison of an absorbable polymer sirolimus-eluting stent to a durable polymer everolimus-eluting stent
Alexandra Lansky, MD; May 2015 ‒ Presentation

DESSOLVE III (ECRI-5): a randomized, controlled clinical trial comparing MiStent to Xience
R.J. de Winter, MD, PhD; May 2015 ‒ Presentation

Redefining bioabsorbable DES with MiStent: drug elution beyond polymer presence
Patrick Serruys, MD, PhD; William Wijns, MD, PhD, Chairpersons; May 2015 ‒ Symposium

Introduction and Session Objectives
Patrick Serruys, MD, PhD

MiStent Technical Overview and Design Intent
John Ormiston, MBChB

The Link Between Preclinical Testing and Clinical Performance and Outcomes
Elazer Edelman, MD, PhD

Clinical Program Overview_DESSOLVE I & II Clinical Outcomes_DESSOLVE III Post-Market Study Design
William Wijns, MD, PhD

Redefining Bioabsorbable DES with MiStent SES: Drug Elution Beyond Polymer Presence_Case Study
Carlo Di Mario, MD, PhD

CRT 2015
Three-year Clinical Update on MiStent SES
Alexandra Lansky, MD; February 2015 ‒ Presentation

GW-ICC 2014
Three Year Results of the DESSOLVE I first-in-human trial and the DESSOLVE II randomized trial of a sirolimus-eluting stent with fully absorbable polymer
Dennis Donohoe, MD; October 2014 ‒ Presentation

TCT 2014
Cobalt Chromium Sirolimus-eluting Platforms VII: MiStent
John Ormiston, MBChB; September 2014 ‒ Presentation

Three-Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating_Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials

John Ormiston, MBChB; Alexandra Lansky, MD; Dennis Donohoe, MD; Mathias Vrolix, MD; Stefan Verheye, MD; Danny Schoors, MD, PhD; William Wijns, MD, PhD on behalf of the DESSOLVE Investigators; September 2014 ‒ Poster

EuroPCR 2014
DESSOLVE II Trial Results_2-Year Follow-up of a Crystalline Sirolimus-Eluting Stent with Rapid Bioabsorbable Polymer

William Wijns, MD, PhD; May 2014 ‒ Presentation
MiStent SES® Clinical Program: DESSOLVE I and II Trials 2/3-Year Follow-up
William Wijns, MD, PhD; May 2014 ‒ Presentation

CRT 2014
MiStent SES® Clinical Program:  DESSOLVE I and II Trials_2-Year Follow-up
Alexandra Lansky, MD; February 2014 ‒ Presentation

TCT 2013
MiStent SES Clinical Program: DESSOLVE I and II Trials_2-Year Follow-up_MiStent SES® Sirolimus Eluting Absorbable Polymer Coronary Stent System
John Ormiston, MBChB; October 2013 ‒ Presentation

EuroPCR 2013
Long-Term Serial Evaluation of Tissue Coverage and Neointimal Hyperplasia by Angiography, IVUS and OCT following Implantation of a Sirolimus Eluting Stent with Absorbable Polymer
Mark Webster, MBChB; May 2013 ‒ Presentation

Minimal Progression of Late Lumen Loss and Stable Clinical Long-Term Results_DESSOLVE I FIH Trial of the MiStent SES®
Joseph Dens, MD, PhD; May 2013 ‒ Presentation

MiStent SES® Absorbable Polymer Coronary Stent System_DESSOLVE Clinical Trials Update
Carlo Di Mario, MD, PhD; May 2013 ‒ Presentation

CRT 2013
DESSOLVE Clinical Trial Program_MiStent® Sirolimus-Eluting Absorbable Polymer Coronary Stent System (MiStent SES™)
Dennis Donohoe, MD; February 2013 ‒ Presentation

Eighteen Month Clinical and Imaging Results from the DESSOLVE I FIH Trial of the MiStent® SES with Absorbable Polymer
John Ormiston, MBChB; Dennis Donohoe, MD; Mathias Vrolix, MD; James Stewart, MBChB; Mark Webster, MBChB; Robert Whitbourn, MBBS; Alexandra Lansky, MD; Hiram Bezzera, MD, PhD; Peter Fitzgerald, MD, PhD; David Kandzari, MD; William Wijns, MD, PhD; February 2013 ‒ Poster

Nine Month Imaging and Twelve Month Clinical Results from the DESSOLVE II Randomized Trial of the MiStent® SES with Absorbable Polymer
William Wijns, MD, PhD; Mathias Vrolix, MD; Stephan Verheye, MD; Danny Schoors, MD, PhD; Ton Slagboom, MD; Marcel Gosselink, MD; Edouard Benit, MD; Walter Desmet, MD, PhD; Saqib Chowdhary, MD, PhD; Alexandra Lansky, MD; Hiram Bezzera, MD, PhD; Peter Fitzgerald, MD, PhD; David Kandzari, MD; John Ormiston, MBChB; February 2013 ‒ Poster

TCT 2012
DESSOLVE MiStent SES Clinical Trial Program_DESSOLVE II: Prospective, Randomized Trial of the Biodegradable Polymer-based Sirolimus-Eluting MiStent versus a Zotarolimus-Eluting Stent
David Kandzari, MD; October 2012 ‒ Presentation

EuroPCR 2012
DESSOLVE I: Twelve Month Results from the FIH Trial of the MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System
Mathias Vrolix, MD; May 2012 ‒ Presentation

CRT 2012
The Micell Technology and Program Update_DESSOLVE I Trial Results
Mathias Vrolix, MD; February 2012 ‒ Presentation

TCT 2011
Micell Crystalline Sirolimus Elution from an Absorbable Polymer_DESSOLVE I Preliminary Trial Results
John Ormiston, MBChB; November 2011 ‒ Presentation

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious
John Ormiston, MBChB; William Wijns, MD, PhD; Mathias Vrolix, MD; James Stewart, MBChB, Mark Webster, MBChB; Robert Whitbourn, MBBS; Alexandra Lansky, MD; Hiram Bezzera, MD, PhD; Peter Fitzgerald, MD, PhD; David Kandzari, MD; October 2011 ‒ Presentation

EuroPCR 2011
MiStent™ DES: A novel third generation DES with a fully-absorbable coating and enhanced drug delivery capabilities
James McClain, PhD; May 2011 ‒ Presentation

CRT 2009
The Micell Rapid Absorption Polymer DES System
David Kandzari, MD; March 2009 ‒ Presentation